General Announcement::iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
15-May-2017 06:50:04
Status
New
Announcement Sub Title
iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX
Announcement Reference
SG170515OTHRHNLX
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

Press Release - iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX.pdf
Total size =259K